Free Access
Neuropeptides and skin: the state of the art
Emiliano Panconesi,
Giuseppe Hautmann,
Torello Lotti,
Corresponding Author
Emiliano Panconesi
Department of Dermatology, University of Florence, Florence, Italy
Prof. E. Panconesi, Dept. of Dermatology, 37. Via Alfani, 50121 Florence, Italy.Search for more papers by this authorGiuseppe Hautmann
Department of Dermatology, University of Florence, Florence, Italy
Search for more papers by this authorTorello Lotti
Department of Dermatology, University of Siena, Siena, Italy
Search for more papers by this authorEmiliano Panconesi,
Giuseppe Hautmann,
Torello Lotti,
Corresponding Author
Emiliano Panconesi
Department of Dermatology, University of Florence, Florence, Italy
Prof. E. Panconesi, Dept. of Dermatology, 37. Via Alfani, 50121 Florence, Italy.Search for more papers by this authorGiuseppe Hautmann
Department of Dermatology, University of Florence, Florence, Italy
Search for more papers by this authorTorello Lotti
Department of Dermatology, University of Siena, Siena, Italy
Search for more papers by this author
References
- 1a Panconesi E. Stress and skin diseases. Lippincott. Philadelphia , 1984.
- 1b
Johnson HM,
Downs MO,
Pontzer CH.
Neuroendocrine peptide hormone regulation of immunity. In: JE Blalock Ed.
Neuroimmunoendocrinology, 2nd Edn.
Basel
. Karger. 1992: 49–83.
10.1159/000319385 Google Scholar
- 2 Blalock JE. Production of peptide hormones and neurotransmitters by the immune system. In: JE Blalock Ed. Neuroimmunoendocrinology. 2nd Edn. Basel , Karger, 1992: 1–24.
- 3
Carr DJJ,
Blalock JE.
Neuropeptide hormones and receptors common to the immune and neuroendocrine systems; bidirectional pathway of intersystem communication. In: R Ader,
DL Felten,
N Cohen, Eds.
Psychoneuroimmunology. 2nd Edn.
Academic Press,
San Diego
, 1991: 573–588.
10.1016/B978-0-12-043780-1.50026-9 Google Scholar
- 4 Goetzl EJ, Turck CW, Sreedharan SP. Production and recognition of neuropeptides by cells of the immune system. In: R Ader, DL Felten, N Cohen, Eds. Psychoneuroimmunology 2nd Edn. Academic Press, San Diego . 1991: 263–282.
- 5 Bellinger DL, Felten SY, Romano TD et al. Neuropeptide innervation of lymphoid organs. Ann NY Acad Sci 1990; 594: 17–33.
- 6 Felten DL, Felten SY. Innervation of the thymus. In: M Kendall Ed. Thymus update 2. London , Harwood Academic, 1989: 73–88.
- 7 Felten DL Felten SY, Carlson SL, et al. Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol 1985: 135: 755s–765s.
- 8
Felten SY,
Felten DL.
The innervation of lymphoid tissue. In: R Ader,
DL Felten,
N Cohen, Eds.
Psychoneuroimmunology
2nd Edn.
Academic Press,
San Diego
. 1991: 27–69.
10.1016/B978-0-12-043780-1.50006-3 Google Scholar
- 9 Karanth SS, Springall DR, Kuhn DM, et al. An immunocytochemical study of cutaneous innervation and the distribution of neuropeptides and protein gene products 9.5 in man and commonly employed laboratory animals. Am J Anat 1991; 191: 369–383.
- 10 Wallengren J, Ekman R, Sundler F. Occurrence and distribution of neuropeptides in the human skin. Acta Dermatol Venereol (Stockholm) 1987; 67: 185–192.
- 11 Hautmann G, Lotti T, Panconesi E. Neuropeptides in the skin. J Am Acad Dermatol submitted.
- 12 Felten DL. Neurotransmitter signaling of cells of the immune system: important progress, major gaps. Brain Behav Immun 1991; 5: 2–8.
- 13
Ader R,
Cohen N.
The influence of conditioning on immune responses. In: R Ader,
DL Felten,
N Cohen, Eds.
Psychoneuroimmunology, 2nd Edn.
Academic Press,
San Diego
, 1991: 611–646.
10.1016/B978-0-12-043780-1.50028-2 Google Scholar
- 14 Ader R, Felten DL, Cohen N. Interactions between the brain and the immune system. Annu Rev Pharmacol Toxicol 1990: 30: 561–602.
- 15 Girolomoni G, Giannetti A. Neuropeptide e cute. G Ital Dermatol Venereol 1989: 124: 121–140.
- 16 Cooper JR, Bloom FE, Roth RH. Biochemical basis of neuropharmacology. 5th Edn. New York , Oxford University Press, 1986: 352–393.
- 17 Pernow B, Substance P. Pharmacol Rev 1983; 35; 85–141.
- 18 Costa M, Furness JB. The origins, pathways and terminations of neurons with VIP-like immunoreactivity in the guinea pig small intestine. Neuroscience 1983; 8: 665–676.
- 19 Morel G, Besson J, Rosselin G, et al. Ultrastructural evidence for endogenous vasoactive intestinal peptide-like immunoreactivity in the pituitary gland. Neuroendocrinology 1982: 34: 85–89.
- 20 Weihe E, Reinecke M. Peptidergic innervation of the mammalian sinus nodes: vasoactive intestinal peptide, neurotensin, substance P. Neurosci Lett 1981: 26: 283–288.
- 21 Bloom SR, Polak JM. Regulatory peptide and the skin. Clin Exp Dermatol 1983: 8: 3–18.
- 22 O'Dorisio MS, Wood CL, O'Dorisio TM. Vasoactive Intestinal Peptide and neuropeptide modulation of the immune response. J Immunol 1985; 135: 792s–794s.
- 23 Ottesen B, Gerstenberg T, Ulrichsen H. Vasoactive Intestinal Polypeptide (VIP) increase vaginal blood flow and inhibits uterine smooth muscle activity in women. Eur J Clin Invest 1983: 13: 321–324.
- 24 Epelbaum J, Tapia-Arancibia L, Besson J. Vasoactive Intestinal Peptide inhibits release of somatostatin from hypothalamus in vitro. Eur J Pharmacol 1979; 58: 493–495.
- 25 Said SI, Geurni A, Hara N. Bronchodilator effect of VIP in vivo: protection against bronchoconstriction induced by histamine or prostaglandin F2a In: SI Said, Ed. Vasoactive Intestinal Peptide. New York , Raven Press, 1982: 185–192.
- 26 Feliu JE, Mojena M, Silvestre RA, et al. Stimulatory effect of vasoactive intestinal peptide on glycogenolysis and gluconeogenesis in isolated rat hepatocytes: antagonism by insulin. Endocrinology 1983; 112: 2120–2127.
- 27 Cutz E, Chan W, Track NS. Release of VIP in mast cells by histamine liberators. Nature (London) 1978: 275: 661–662.
- 28 O'Dorisio MS, O'Dorisio TM, Cataland S. VIP us a biochemical marker for polymorphonuclear leukocytes. J Lab Clin Med 1990; 96: 666–672.
- 29 Payan DJ, Hess CA, Goetzl EJ. Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts. Cell Immunol 1984; 84: 433–438.
- 30 Stanisz AM, Befus D, Bienenstock J. Differential effects of vasoactive intestinal peptide, substance p. and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol 1986; 136: 152–156.
- 31 Muscettola M, Grasso G. Somatostatin and vasoactive intestinal peptide reduce interferon gamma production by human peripheral blood mononuclear cells. Immunobiology 1990: 180: 419–430.
- 32 Wagner M, Hengst K, Zierden E. et al. Investigations of the antiproliferative effect of somatostatin in man and rats. Metab Clin Exp 1979: 27: 1381–1386.
- 33 Hinterberger W, Cerny C, Kinast M, et al. Somatostatin reduces the release of colony-stimulating activity (CSA) from PHA-activated mouse spleen lymphocytes. Experientia 1977: 34: 860–862.
- 34 Sreedharan SP, Kodama KT, Peterson KE, et al. Distinct subsets of somatostatin receptors on cultured human lymphocytes. J Biol Chem 1989; 264: 949–952.
- 35 Nakamura H, Koike T, Hiruma K. et al. Identification of lymphoid cell lines bearing receptors for somatostatin. Immunology 1987; 62: 655–658.
Citing Literature
